RB,
You have missed my point. We have had NO INVESTMENT IN NUSEP. And we're borrowing money at 12% and implicitly lending it for free to Mr Goh. I don't know about you, but that seems like a bad business model. And these guys have been the champions of bad business models.
And I am not sure we really have had a $6m investment in PRIME. Who valued it at $6m? And why isn't anyone now valuing NuSep at A$40m if we own the other 90% (+ all of the other value)?
RB, either you are an incredible genius and all of these professionals, including pharma companies are morons or you have been deluded about the truth. For me, I just don't know.....
institutional investors, page-10
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $13.00M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.6¢ | 0.5¢ | $49.30K | 9.656M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 2234999 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 5372603 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MEM (ASX) Chart |
